Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ZVRA Zevra Therapeutics
- 8.480
- +0.040+0.47%
Close Dec 13 16:00 ET
- 8.380
- -0.100-1.18%
Post 19:54 ET
452.63MMarket Cap-3.98P/E (TTM)
8.740High8.350Low399.54KVolume8.390Open8.440Pre Close3.41MTurnover0.93%Turnover RatioLossP/E (Static)53.38MShares9.76052wk High6.49P/B365.35MFloat Cap4.20052wk Low--Dividend TTM43.08MShs Float418.400Historical High--Div YieldTTM4.62%Amplitude2.560Historical Low8.527Avg Price1Lot Size
Zevra Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -291.98%-18.14M | -119.54%-19.11M | -299.63%-16.17M | -79.17%-33.54M | -262.12%-16.16M | 29.86%-4.63M | -112.09%-8.7M | -13.85%-4.05M | -279.30%-18.72M | -426.18%-4.46M |
| Net income from continuing operations | -220.49%-33.23M | -674.39%-19.93M | -25.76%-16.62M | -72.00%-46.05M | -445.95%-19.89M | -56.70%-10.37M | 89.30%-2.57M | -609.07%-13.22M | -212.94%-26.77M | 312.73%5.75M |
| Operating gains losses | 237.86%4.71M | -202.49%-5.82M | -360.38%-3.4M | 100.37%57K | 127.34%4.09M | -15,413.64%-3.41M | -8,265.22%-1.92M | 641.49%1.31M | -194.09%-15.24M | -22,559.09%-14.96M |
| Depreciation and amortization | 2,508.06%1.62M | 1,902.56%1.56M | 1,877.22%1.56M | 6.57%1.01M | 162.33%787K | -84.42%62K | -56.91%78K | 21.54%79K | 267.32%944K | 368.75%300K |
| Other non cash items | 1,208.45%929K | 2,556.00%664K | 602.38%295K | -98.73%227K | 50.85%89K | 9.23%71K | -99.86%25K | -16.00%42K | 3,788.48%17.89M | -21.33%59K |
| Change In working capital | -103.08%-239K | 77.25%-1.44M | -102.12%-148K | 1,549.01%5.88M | -172.89%-2.54M | 626.61%7.76M | -1,628.99%-6.33M | 346.98%7M | -13.73%-406K | 263.50%3.49M |
| -Change in receivables | -71.82%1.16M | 89.66%-642K | 1,801.89%9.07M | -34.05%-9.08M | -250.42%-7.45M | 222.42%4.11M | -1,342.20%-6.21M | 126.62%477K | -744.34%-6.77M | -2,436.26%-2.13M |
| -Change in inventory | -996.92%-583K | -1,439.19%-991K | -5,168.63%-2.59M | 40.14%206K | 112.03%16K | -73.03%65K | 89.74%74K | --51K | --147K | ---133K |
| -Change in prepaid assets | 13.26%410K | 21.19%-818K | -106.26%-44K | 117.00%152K | -58.61%125K | -47.99%362K | 52.71%-1.04M | 132.01%703K | -8.36%-894K | -44.18%302K |
| -Change in payables and accrued expense | -181.04%-1.99M | -45.78%-1.3M | -290.46%-7.31M | 255.48%11.13M | 206.58%5.73M | 288.13%2.45M | -179.66%-889K | 889.30%3.84M | 381.31%3.13M | 140.23%1.87M |
| -Change in other current assets | 927.27%91K | 116.05%175K | 53.75%123K | -51.58%321K | -70.57%171K | -110.38%-11K | 208.00%81K | 56.86%80K | 398.50%663K | 1,191.11%581K |
| -Change in other current liabilities | -9,150.00%-1.48M | 473.81%482K | -232.92%-428K | 82.94%-79K | -779.71%-469K | 89.74%-16K | -84.24%84K | 135.42%322K | -216.62%-463K | 113.91%69K |
| -Change in other working capital | 169.92%2.15M | 5.16%1.65M | -33.25%1.02M | -14.57%3.23M | -122.71%-664K | 120.44%798K | --1.57M | --1.53M | --3.78M | --2.92M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -291.98%-18.14M | -119.54%-19.11M | -299.63%-16.17M | -79.17%-33.54M | -262.12%-16.16M | 29.86%-4.63M | -112.09%-8.7M | -13.85%-4.05M | -279.30%-18.72M | -426.18%-4.46M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 29.47%-31.35M | -100.38%-129K | 184.27%14.79M | 52.64%-17.39M | 16,901.59%10.59M | -16,444.12%-44.46M | 202.89%34.04M | -356.21%-17.56M | -136.53%-36.72M | 99.59%-63K |
| Net PPE purchase and sale | --0 | --0 | --0 | -218.28%-296K | -111.76%-72K | -514.29%-172K | -53.33%-23K | -81.25%-29K | 8.82%-93K | -100.00%-34K |
| Net business purchase and sale | ---- | ---- | ---- | -115.76%-30.4M | ---- | ---- | ---- | ---- | ---14.09M | --0 |
| Net investment purchase and sale | 29.20%-31.35M | -100.38%-129K | 184.41%14.79M | 159.05%13.31M | 141,679.31%41.06M | -14,861.33%-44.28M | 279.49%34.06M | -357.36%-17.53M | -46.13%-22.54M | 99.81%-29K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 29.47%-31.35M | -100.38%-129K | 184.27%14.79M | 52.64%-17.39M | 16,901.59%10.59M | -16,444.12%-44.46M | 202.89%34.04M | -356.21%-17.56M | -136.53%-36.72M | 99.59%-63K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 146.64%64.77M | 1,511.99%15.33M | 132.45%1.22M | 240.80%28.46M | 2,047.08%5M | 6,520.29%26.26M | -93.08%951K | 20.77%-3.75M | -92.62%8.35M | 91.05%-257K |
| Net issuance payments of debt | --0 | 5,159.01%16.29M | --0 | 94.74%24.9M | -36,600.00%-1.1M | 1,310,400.00%26.21M | -102.52%-322K | 1,220.00%112K | 133.56%12.78M | 82.35%-3K |
| Net common stock issuance | --64.67M | ---71K | 135.31%1.22M | 156.30%2.66M | --6.11M | --0 | --0 | 27.02%-3.45M | -110.16%-4.72M | --0 |
| Proceeds from stock option exercised by employees | 73.58%92K | ---- | ---- | -32.72%218K | -100.93%-1K | --53K | ---- | ---- | -98.95%324K | --108K |
| Net other financing activities | --0 | ---- | ---- | 2,196.97%692K | --0 | --0 | --1.11M | ---415K | -100.04%-33K | -828.21%-362K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 146.64%64.77M | 1,511.99%15.33M | 132.45%1.22M | 240.80%28.46M | 2,047.08%5M | 6,520.29%26.26M | -93.08%951K | 20.77%-3.75M | -92.62%8.35M | 91.05%-257K |
| Net cash flow | ||||||||||
| Beginning cash position | -40.69%39.26M | 6.64%42.85M | -34.24%43.05M | -41.73%65.47M | -38.24%43.27M | -13.78%66.2M | -59.90%40.18M | -41.73%65.47M | 2,499.40%112.35M | -46.72%70.06M |
| Current changes in cash | 166.90%15.27M | -114.87%-3.91M | 99.39%-155K | 52.30%-22.46M | 88.10%-569K | -238.90%-22.83M | 212.16%26.28M | -108.92%-25.35M | -143.59%-47.08M | 75.04%-4.78M |
| Effect of exchange rate changes | -381.37%-491K | 219.03%319K | -169.23%-45K | -78.43%44K | 84.66%349K | -780.00%-102K | ---268K | --65K | --204K | --189K |
| End cash Position | 24.89%54.04M | -40.69%39.26M | 6.64%42.85M | -34.24%43.05M | -34.24%43.05M | -38.24%43.27M | -13.78%66.2M | -59.90%40.18M | -41.73%65.47M | -41.73%65.47M |
| Free cash flow | -277.94%-18.14M | -118.96%-19.11M | -296.78%-16.17M | -79.86%-33.83M | -260.99%-16.23M | 27.56%-4.8M | -111.87%-8.73M | -14.15%-4.07M | -281.97%-18.81M | -419.77%-4.5M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.